650-274-8199
Quick Selection.png
Visit
  • Twitter - White Circle
  • LinkedIn - White Circle
©2019 BY NEUCYTE, INC.

Epilepsy pipeline conference

March 12-13,2020

 Santa Clara,Ca

Come Join Us!

Interested in epilepsy treatment, therapeutic innovation, and product development? Join us at the Epilepsy Foundation Pipeline Conference, March 12-13, 2020 (To be rescheduled)

Register here!

The Epilepsy Foundations Pipeline Conference brings together decision makers with a stake in the field of epilepsy treatment, therapeutic innovation, and product development.

Join NeuCyte's Presentations

NC-201

This is a first-in-class drug candidate for treating refractory epilepsy with unique MoA. It shows superior and broad efficacy and preclinical safety profiles, and better anti-seizure efficacy than benchmark AEDs in 11 epilepsy animal models. It’s gained NIH “Red Book” status and been highly anticipated by epilepsy researchers and neurologists.

This presentation will be included in Session V, Day 1.

Date: March 12, 2020 (To be rescheduled)

Session Title: What We Still Need in Drugs for Focal Epilepsy

Session Time: 1:55 pm

Hui Liu PhD, Director, Drug Discovery, NeuCyte

NeuCyte's Platform

Based on its proprietary technology for generating human iPSC-derived induced neuronal cells, NeuCyte has developed an in vitro human neural platform for complex electrophysiological and morphological readouts suited for target identification and validation, efficacy testing, and neurotoxicity assessment. Using patient-derived and genetically engineered defined neural cell types, NeuCyte builds unique cell-based assays for modeling neurological and neurodegenerative disorders.

This presentation will be included in Session VI, Day 2.

Date: March 13, 2020 (To be rescheduled)

Session Title: Screening

Session Time: 8:15 am

Thomas Portmann PhD,

Head of Research, NeuCyte

Every two years, The Epilepsy Foundation hosts a one-day educational conference dedicated to people with epilepsy, their families and friends, and community supporters. Learn about #CommunityDay2020 on March 14 in Santa Clara, CA: epilepsy.com/CommunityDay2020

NeuCyte is committed to developing epilepsy treatment. For more information about our drug discovery programs, please visit: neucyte.com/drug-discovery.